{"result": {"id": "df0bcf6c-756a-490c-9a9d-333caf16bfdf", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CKD<|>ORGANIZATION<|>Chronic Kidney Disease, a condition where tumor patients may need stricter blood pressure control>)  \n##  \n(\"entity\"<|>DIABETES<|>ORGANIZATION<|>A comorbidity that influences blood pressure targets in tumor patients>)  \n##  \n(\"entity\"<|>CYP3A4<|>ORGANIZATION<|>Enzyme whose inhibition by certain drugs can increase chemotherapy toxicity>)  \n##  \n(\"entity\"<|>CHEMOTHERAPY<|>EVENT<|>Cancer treatment that may interact with blood pressure medications>)  \n##  \n(\"relationship\"<|>TUMOR PATIENTS<|>CKD<|>Tumor patients with CKD require adjusted blood pressure targets<|>7>)  \n##  \n(\"relationship\"<|>TUMOR PATIENTS<|>DIABETES<|>Tumor patients with diabetes require stricter blood pressure control<|>7>)  \n##  \n(\"relationship\"<|>NON-DIHYDROPYRIDINE CCB<|>CYP3A4<|>Non-dihydropyridine CCBs inhibit CYP3A4, increasing chemotherapy risks<|>8>)  \n##  \n(\"relationship\"<|>CHEMOTHERAPY<|>CYP3A4<|>Chemotherapy drug metabolism can be affected by CYP3A4 inhibitors<|>8>)  \n##  \n(\"relationship\"<|>DIHYDROPYRIDINE CCB<|>CHEMOTHERAPY<|>Dihydropyridine CCBs are safer for patients undergoing chemotherapy<|>7>)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558776, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 365, "prompt_tokens": 3092, "total_tokens": 3457, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3008}, "prompt_cache_hit_tokens": 3008, "prompt_cache_miss_tokens": 84}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �量 1 次诊室血  压 ,之后至少每 2~3周测量 1次 。肿瘤患者血压需要  准确测量并考虑潜在的混杂因素、辅助治疗、焦虑情绪  和疼痛刺激等可暂时升高血压读数的因素 , 因此诊室  外血压测量同样重要 ,必要时可通过动态血压准确评  估 。在第一个肿瘤治疗周期后血压稳定时推荐家庭自  测血压用于监测 ,评估和滴定降压药[634] 。\n　8.10.2  治疗起始阈值与血压目标值   肿瘤患者高血 压的治疗不仅取决于血压水平、心血管危险分层 ,还需 考虑肿瘤的预后 ,不同情况起始治疗阈值见表 27。\n　　　建 议 在 肿 瘤 治 疗 期 间 血 压 目 标 值 < 140/ 90mmHg,若患者合并糖尿病、CKD 可将血压降至  130/80mmHg[635]  ,血压 <130/80 mmHg的 目标值  在肿瘤患者中尚无确切证据[28] 。在无症状转移癌患  者中 ,密切监测血压的情况下可以将降压目标值维持  在 收 缩 压  140 ~ 160  mmHg 和 舒 张 压  90 ~  100mmHg[635] 。\n\n表 27  肿瘤患者降压治疗起始阈值\n\n收缩压(mmHg)\t癌症存活者\t可治愈癌症治疗期\t癌症预后>3年\t癌症预后 1~3年\t癌症预后<1年\n≥160\t应治疗\t应治疗\t应治疗\t应治疗\t应治疗\n140~159\t应治疗\t应治疗\t应治疗\t需治疗\t可治疗\n135~139\t应治疗\t可治疗\t需治疗\t可治疗\t不治疗\n130~134\t可治疗\t不治疗\t不治疗\t不治疗\t不治疗\n\n\n\n　8.10.3   降压治疗   改善生活方式 :无论采用何种抗 癌疗法 ,都建议改变生活方式和在不影响进食的情况 下适当减少钠摄入量 。然而 ,仅通过改变生活方式难 以实现肿瘤患者的血压目标值[636] 。肿瘤患者降压药 的选择应考虑治疗的特异性疾病和靶器官损害。\n　　　药 物 治 疗 : 推 荐 ACEI或 ARB及 二 氢 吡 啶 类  CCB作为一线治疗以降低肿瘤治疗相关心血管毒性  和肾损伤的风险[637] 。 当收缩压 ≥160mmHg和/或  舒张压≥100mmHg时 ,建议 ACEI或 ARB与二氢吡  啶类 CCB联合治疗 。不建议应用非二氢吡啶类 CCB (地尔硫和维拉帕米) , 因其可通过抑制 CYP3A4干  扰化疗药物代谢增加化疗毒性的风险 。应用利尿剂时  需警惕因化疗引起的恶心和呕吐或脱水导致急性肾损\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>TUMOR PATIENTS<|>PERSON<|>Patients with tumors who require accurate blood pressure measurement and management due to potential confounding factors and treatments>  \n##  \n(\"entity\"<|>BLOOD PRESSURE MEASUREMENT<|>EVENT<|>Process of measuring blood pressure in tumor patients, considering factors like anxiety, pain, and treatments that may affect readings>)  \n##  \n(\"entity\"<|>HOME BLOOD PRESSURE MONITORING<|>EVENT<|>Recommended method for stable tumor patients to monitor blood pressure after the first treatment cycle>)  \n##  \n(\"entity\"<|>ANTIHYPERTENSIVE THERAPY<|>EVENT<|>Treatment for hypertension in tumor patients, involving lifestyle changes and medication, with specific thresholds based on cancer prognosis>)  \n##  \n(\"entity\"<|>ACEI/ARB<|>ORGANIZATION<|>Class of drugs recommended as first-line treatment for tumor patients to reduce cardiovascular and kidney risks>)  \n##  \n(\"entity\"<|>DIHYDROPYRIDINE CCB<|>ORGANIZATION<|>Class of calcium channel blockers recommended for tumor patients with hypertension>)  \n##  \n(\"entity\"<|>NON-DIHYDROPYRIDINE CCB<|>ORGANIZATION<|>Class of calcium channel blockers not recommended due to interference with chemotherapy metabolism>)  \n##  \n(\"relationship\"<|>TUMOR PATIENTS<|>BLOOD PRESSURE MEASUREMENT<|>Tumor patients require accurate blood pressure measurement due to treatment-related factors<|>8>)  \n##  \n(\"relationship\"<|>TUMOR PATIENTS<|>HOME BLOOD PRESSURE MONITORING<|>Tumor patients are recommended to use home monitoring for stable blood pressure management<|>7>)  \n##  \n(\"relationship\"<|>TUMOR PATIENTS<|>ANTIHYPERTENSIVE THERAPY<|>Tumor patients may require antihypertensive therapy based on blood pressure levels and cancer prognosis<|>9>)  \n##  \n(\"relationship\"<|>ANTIHYPERTENSIVE THERAPY<|>ACEI/ARB<|>ACEI/ARB drugs are recommended as first-line treatment for tumor patients with hypertension<|>8>)  \n##  \n(\"relationship\"<|>ANTIHYPERTENSIVE THERAPY<|>DIHYDROPYRIDINE CCB<|>Dihydropyridine CCB is recommended for tumor patients with high blood pressure<|>7>)  \n##  \n(\"relationship\"<|>NON-DIHYDROPYRIDINE CCB<|>CHEMOTHERAPY<|>Non-dihydropyridine CCB is not recommended due to its interference with chemotherapy metabolism<|>6>)  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_5fff80177f520eb012effbd9e7b2adcdd3e921f265b9b0a921f00d3c089f0dfa_v2"}